Cancer Prevention and Control

The Cancer Prevention and Control research program coordinates and promotes all of the cancer prevention and control-related research activities within the Winship Cancer Institute of Emory University.

Led by program leader, Roberd “Robin” M. Bostick, MD, MPH and program co-leader, Andrew Miller, MD, the Cancer Prevention and Control Program capitalizes on being in a major research university with schools of medicine and nursing and a highly ranked school of public health from which to build a cancer center program that addresses a full spectrum of cancer prevention and control research.

The broad, long-term goals of the Cancer Prevention and Control Program are to reduce cancer risk, incidence, morbidity, and mortality, and to improve the quality of life of cancer patients and survivors in Georgia and beyond.

These goals are addressed through the following four primary scientific themes:

Cancer Epidemiology, Biomarkers, and Chemoprevention: Describing and tracking cancer incidence and mortality trends of all cancers; conducting population-based etiologic research in humans; and conducting chemoprevention trials in Georgia and in national collaborations.
Health Behavior Research: Conducting population-based research that applies social science research methods, including theories of human behavior and rigorous measurement, to preventing cancers and detecting them in an early, treatable stage.
Symptom Management and Control: Conducting research that characterizes the scope, mechanisms, and consequences of behavioral co-morbidities in cancer patients, while also identifying patients at risk for these co-morbidities and developing novel pharmacologic and non-pharmacologic prevention and treatment strategies.
Health Outcomes and Quality of Care: Conducting population-based research that describes, interprets, and predicts the impact of interventions and other factors on cancer outcomes important to decision makers.

In addition to these four primary scientific themes, research involving inflammation/oxidative balance, biomarkers, and health disparities represent inter-thematic common elements that are also serving to promote inter-programmatic collaborations.

Cancer Prevention and Control program members are continuously publishing landmark research in high-impact scientific journals.

View Publications by Program Members

To learn more about the Cancer Prevention and Control research program at Winship Cancer Institute, please contact Greg Cheek at (404) 727-2658.

Visit the Emory University's Cancer Biology Graduate Program website to learn about outstanding training opportunities in every aspect of cancer research, from basic to translational.

Roberd Bostick, MD, MPH

Program Leader, Cancer Prevention and Control Research Program: Winship Cancer Institute of Emory University

Dr. Bostick leads the Cancer Prevention and Control program which coordinates and promotes all of the cancer prevention and control-related research activities at Winship.

Andrew H. Miller, MD

Co-Leader, Cancer Prevention and Control Research Program: Winship Cancer Institute of Emory University

Dr. Miller is an internationally recognized leader in the area of brain-immune interactions as they relate to stress and depression.

Cascade Link

Kathleen E. Adams, PhD: Professor, Department of Health Policy and Management , Rollins School of Public Health of Emory University

Ana Antun, MD: Instructor of Hematology and Medical Oncology, Emory University Hospital Midtown

Kimberly Jacob Arriola, PhD, MPH: Associate Professor, Department of Behavioral Sciences and Health Education, Rollins School of Public Health of Emory University

Wendy Baer, MD: Medical Director of Psychiatric Oncology, Winship Cancer Institute of Emory University

George Richard Beck Jr., PhD: Associate Professor, Department of Medicine, Division of Endocrinology, Emory University School of Medicine

Robert A. Bednarczyk, PhD: Assistant Professor, Hubert Department of Global Health, Rollins School of Public Health, Emory University

Carla J. Berg, PhD: Assistant Professor, Department of Behavioral Sciences & Health Education, Rollins School of Public Health of Emory University

Roberd Bostick, MD, MPH: Program Leader, Cancer Prevention and Control Research Program, Winship Cancer Institute of Emory University

Otis Brawley, MD: Professor, Department of Hematology and Oncology, Emory University School of Medicine

Amy Y. Chen, MD, MPH, FACS: Willard and Lillian Hackerman Professor of Otolaryngology, Head and Neck Surgery, Emory University School of Medicine

Suephy Chen, MD, MS: Director, Dermatology Clinical and Outcomes Research Unit, Winship Cancer Institute of Emory University

John W. Eley, MD, MPH: Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine

Carla L. Ellis, MD. MS: Assistant Professor, Department of Pathology and Laboratory Medicine, Emory University School of Medicine

Natia Esiashvili, MD: Associate Professor, Department of Radiation Oncology, Emory University School of Medicine

Felix G. Fernandez, MD: Chief, Section of Cardiothoracic Surgery, Atlanta Veterans Affairs Medical Center

Christopher R. Flowers , MD: Director of the Emory Lymphoma Program, Winship Cancer Institute of Emory University

Sheryl Gabram-Mendola, MD, MBA, FACS: Surgeon-in-Chief, Grady Memorial Hospital

Theresa W. Gillespie, PhD, MA, BSN: Associate Professor, Department of Surgery, Emory University School of Medicine

Mary M. Gullatte, PhD, RN, ANP-BC, AOCN, FAAN: Corporate Director of Nursing Innovation and Research, Emory Healthcare

Ebrahim Haroon, MD: Assistant Professor, Department of Psychiatry and Behavioral Sciences, Emory School of Medicine

Ira R. Horowitz, MD, SM: Chief Medical Officer, Emory University Hospital

David H. Howard , PhD: Associate Professor, Health Policy and Management, Rollins School of Public Health, Emory University

Yijian (Eugene) Huang, PhD: Professor, Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University

Cheng Huang, PhD: Assistant Professor, Department of Global Health and the Department of Environmental and Occupational Health, School of Public Health and Health Services of George Washington University

Ashesh Jani, MD, MSEE: Director, Residency Program, Department of Radiation Oncology, Emory University School of Medicine

Anand P. Jillella, MD: Associate Director for Community Outreach, Winship Cancer Institute of Emory University

Shannon Kahn, MD: Assistant Professor, Department of Radiation Oncology, Emory University School of Medicine

Michelle C. Kegler, DrPH, MPH: Professor, Department of Behavioral Sciences & Health Education, Rollins School of Public Health of Emory University

Namita Khanna, MD, MSPH: Director, Pelvic Surgery Fellowship, Department of Gynecology and Obstetrics, Emory University School of Medicine

Adam Klein, MD: Assistant Professor, Department of Otolaryngology, Emory University School of Medicine

Omer Kucuk, MD: Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine

Michael Kutner, PhD: Professor, Department of Biostatistics and Bioinformatics, Rollins School of Public Health, Emory University

Timothy L. Lash, DSc, MPH: Professor, Department of Epidemiology, Rollins School of Public Health, Emory University

Joseph Lipscomb, PhD: Professor of Health Policy and Management, Rollins School of Public Health

Viraj Master, MD, PhD, FACS: Associate Professor, Department of Urology, Emory University School of Medicine

Douglas E. Mattox, MD: William Chester Warren, Jr., MD Chair and Professor, Otolaryngology, Head and Neck Surgery, Emory University School of Medicine

Colleen McBride, PhD: Rollins Professor and Chair, Department of Behavioral Sciences & Health Education, Rollins School of Public Health of Emory University

Andrew H. Miller, MD: Co-Leader, Cancer Prevention and Control Research Program, Winship Cancer Institute of Emory University

Charles E. Moore, MD: Chief of Service, Otolaryngology, Grady Memorial Hospital

Gregg Orloff, PhD: Assistant Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine

Susmita Parashar, MD, MPH, MS: Director, Winship at Emory Cardio-Oncology Program, Winship Cancer Institute of Emory University

Maria Ribeiro, MD: Chief, Section of Hematology & Oncology, Atlanta Veterans Affairs Medical Center

Monica Rizzo, MD, FACS: Associate Professor, Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine

P. Barry Ryan, PhD, MS: Professor, Department of Environmental Health, Rollins School of Public Health of Emory University

Martin G. Sanda, MD: Professor and Chairman, Department of Urology, Emory University School of Medicine

Dong Moon Shin, MD, FACP: Associate Director for Academic Development, Winship Cancer Institute of Emory University

Patrick Sullivan, MD: Assistant Professor, Division of Surgical Oncology, Department of Surgery, Emory University School of Medicine

Jeffrey Switchenko, PhD, MS: Assistant Research Professor, Department of Biostatistics and Bioinformatics, Rollins School of Public Health of Emory University

Mylin A. Torres, MD: Associate Professor, Department of Radiation Oncology, Emory University School of Medicine

Drenna Waldrop-Valverde, PhD: Associate Professor, Department of Nursing, Nell Hodgson Woodruff School of Nursing of Emory University

Deborah Watkins Bruner, RN, PhD, FAAN: Associate Director for Outcomes Research, Winship Cancer Institute of Emory University

William G. Woods, MD: Pediatric Hematology/Oncology Director and the Daniel P. Amos Children's Chair, Aflac Cancer and Blood Disorders Center

Canhua Xiao, PhD, MSN, BSN: Research Assistant Professor, Nell Hodgson Woodruff School of Nursing of Emory University

Kate Yeager, PhD, RN, MS: Research Assistant Professor, Nell Hodgson Woodruff School of Nursing of Emory University

Cancer Prevention and Control

Overview

Goals and Scientific Themes

Publications

Program Contact

Program Leaders

Roberd Bostick, MD, MPH

Andrew H. Miller, MD

All Program Members